Carriers of m.3243A>G Who Receive Transplant Must be Closely Monitored for Possible Mitochondrial Toxicity of Required Immunosuppressants.

IF 0.7 4区医学 Q4 TRANSPLANTATION

Experimental and Clinical Transplantation Pub Date : 2025-08-01 DOI:10.6002/ect.2025.0099

Josef Finsterer

引用次数: 0

查看原文本刊更多论文

接受移植的m.3243A >g携带者必须密切监测所需免疫抑制剂可能的线粒体毒性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Experimental and Clinical Transplantation 医学-移植

CiteScore

1.40

自引率

11.10%

发文量

258

审稿时长

6-12 weeks

期刊介绍： The scope of the journal includes the following: Surgical techniques, innovations, and novelties; Immunobiology and immunosuppression; Clinical results; Complications; Infection; Malignancies; Organ donation; Organ and tissue procurement and preservation; Sociological and ethical issues; Xenotransplantation.